Related Experiment Videos
Parkinson's disease with camptocormia.
F Bloch1, J L Houeto, S Tezenas du Montcel
1Centre d'Investigation Clinique-Fédération des Maladies du Système Nerveux, Groupe-Hospitalier Pitié-Salpêtrière, Paris, France.
Journal of Neurology, Neurosurgery, and Psychiatry
|June 7, 2006
Summary
Camptocormia in Parkinson's disease patients often presents as axial dystonia, characterized by levodopa-unresponsive symptoms. This suggests a specific Parkinson's disease subtype possibly linked to non-dopaminergic basal ganglia dysfunction.
Area of Science:
- Neurology
- Movement Disorders
- Neuroscience
Background:
- Camptocormia, an abnormal trunk flexion, is of unknown origin, often linked to muscle myopathy or motor neuron disorders.
- It is observed in a subset of patients experiencing parkinsonism.
Purpose of the Study:
- To characterize clinical and electrophysiological features of camptocormia in Parkinson's disease (PD).
- To compare patients with PD and camptocormia against those with PD alone.
Main Methods:
- Prospective multidisciplinary assessment (neurological, psychological, rheumatological, neurophysiological) of patients with parkinsonism and camptocormia.
- Exclusion of multiple system atrophy patients.
- Comparison with age-matched PD patients without camptocormia.
Main Results:
- Camptocormia developed after 8.5 years of parkinsonism and showed poor levodopa response (20%), indicating axial dystonia.
- Patients exhibited levodopa-unresponsive axial symptoms (rigidity, gait disorder, postural instability).
- Increased antisaccade paradigm errors were noted in the camptocormia group.
Conclusions:
- Parkinsonian features in camptocormia patients suggest a specific PD form with axial dystonia.
- Camptocormia and parkinsonism may stem from additional non-dopaminergic basal ganglia dysfunction.